Munich-based biotechnology startup Twogee Biotech has secured €2.16 million in funding to accelerate the development of its technology that converts residual biomass into sustainable, bio-based building blocks for industrial use.
The fresh capital will support Twogee Biotech’s mission to replace fossil-based raw materials with renewable alternatives by unlocking value from agricultural and industrial biomass waste streams. Using proprietary biotechnological processes, the company transforms residual biomass into functional molecular building blocks that can be used across multiple industries, including chemicals, materials, and manufacturing.
According to the company, the funding will be used to scale its technology, expand pilot production, and strengthen partnerships with industrial players seeking to decarbonise their supply chains. By focusing on waste and by-products rather than food crops, Twogee Biotech aims to contribute to a circular bioeconomy while avoiding competition with food systems.
Twogee Biotech’s approach addresses a growing demand for sustainable inputs as industries face increasing pressure to reduce emissions and dependence on fossil resources. Bio-based building blocks are seen as a critical component in the transition toward greener value chains, offering comparable performance with a significantly lower environmental footprint.
With this latest investment, Twogee Biotech positions itself as a key player in Europe’s climate tech and industrial biotech ecosystem, advancing scalable solutions that turn waste into high-value, sustainable materials.
